Active — Not RecruitingNot Applicable

Evaluation of Proton Therapy in Pediatric Cancer Patients

United States1,000 participantsStarted 2017-08-01

Plain-language summary

This is a Phase IV clinical trial observing and evaluating the safety of proton therapy in children. Protocol therapy is not being done as part of this clinical trial. The radiation targeting, planning, prescribed dose, fractionation, schedule, and use of other forms of therapy will be done per other therapeutic protocols at St. Jude Children's Research Hospital (SJCRH) at the discretion of the treating physicians associated with those trials.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patient is planned for treatment or has been treated with proton therapy at St. Jude Children's Research Hospital on or after November 18, 2015. Exclusion Criteria: * Patients who are currently pregnant will not be enrolled in the study as radiation has teratogenic or abortifacient effects. In the rare case that a patient was previously pregnant as a young adult, the patient will be considered eligible for enrollment.

What they're measuring

Incidence of radiation-associated non-hematologic toxicities

Timeframe: From baseline through 10 years

Trial details

NCT IDNCT03223766

SponsorSt. Jude Children's Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2037-07

View on ClinicalTrials.gov More Tumor trials